Skip to main content

Table 1 Clinical variables examined

From: The role of LDH serum levels in predicting global outcome in HCC patients treated with sorafenib: implications for clinical management

Clinical variables

LDH

LDH

LDH

LDH

Total

≤407 U/l

>407 U/l

Decreased

Increased

Patients

53 (%)

25 (%)

26

52

78

Gender

Male

52 (98)

21 (84)

24 (92)

49 (94)

73

Female

1 (2)

4 (16)

2 (8)

3 (6)

5

Median age

< 69

28 (53)

11 (44)

12 (46)

27 (52)

39

≥ 69

25 (47)

14 (56)

14 (54)

25 (48)

39

ECOG

0

36 (68)

16 (64)

15 (58)

37 (71)

52

1-2

17 (32)

9 (36)

11 (42)

15 (29)

26

BCLC

B

14 (26)

10 (40)

8 (32)

16 (31)

24

C

39 (74)

15 (60)

18 (68)

36 (69)

54

Median serum α-FP level

≥ 19 ng/mL

13 (25)

7 (28)

5 (19)

15 (29)

20

< 19 ng/mL

40 (75)

18 (72)

21 (81)

37 (71)

58

Comorbidities (>5%)

Cardiovascular

11 (21)

4 (16)

5 (19)

10 (19)

15

Diabetes

6 (11)

2 (8)

3 (12)

5 (10)

8

Other previous neoplasm

3 (6)

0 (0)

1 (4)

2 (4)

3

Etiology

HCV

20 (38)

9 (36)

10 (38)

19 (37)

29

HBV

13 (24)

7 (28)

5 (19)

15 (29)

20

HBV-HCV

2 (4)

0 (0)

1 (4)

1 (2)

2

Alcoholic

9 (17)

5 (20)

7 (27)

7 (13)

14

Alcoholic - HBV-HCV

0 (0)

1 (4)

0 (0)

1 (2)

1

Methabolic-Cryptogenetic

9 (17)

3 (12)

3 (12)

9 (17)

12

Prior locoregional treatments

Yes

25 (47)

13 (52)

15 (58)

23 (44)

38

No

28 (53)

12 (48)

11 (42)

29 (56)

40

Prior surgery

Yes

11 (21)

4 (16)

6 (23)

9 (17)

15

No

42 (79)

21 (84)

20 (77)

43 (83)

63

AST

< UNR (40 U/L)

19 (36)

9 (36)

14 (54)

14 (27)

28

≥ UNR (40 U/L)

34 (64)

16 (64)

12 (46)

38 (73)

50

ALT

< UNR (40 U/L)

23 (43)

11 (44)

9 (35)

25 (48)

34

≥ UNR (40 U/L)

30 (57)

14 (56)

17 (65)

27 (52)

44

CRP

< UNR (0.5 mg/dL)

11 (21)

4 (16)

6 (23)

9 (17)

15

≥ UNR (0.5 mg/dL)

42 (79)

21 (84)

20 (77)

43 (83)

63

Viral load HCV RNA

< 5.3 log10 IU/mL

7 (35)

5 (56)

3 (30)

9 (47)

12

≥ 5.3 log10 IU/mL

13 (65)

4 (44)

7 (70)

10 (53)

17

Viral load HBC DNA

< 2000 IU/mL

6 (46)

3 (43)

3 (60)

6 (40)

9

≥ 2000 IU/ml

7 (54)

4 (57)

2 (40)

9 (60)

11

  1. ECOG PS (Eastern Cooperative Oncology Group performance status), BCLC (Barcelona Clinic Liver Cancer), AST (aspartate aminotransferase), ALT (alanine aminotransferase), CRP (C reactive protein), UNR (upper normal rate).